Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Autosomal Dominant Spastic Paraplegia Type 8 , Sequencing KIAA0196 Reference Laboratory Genetics Spain | 1 | 1 |
|
HSP, Complete Dominant Evaluation Athena Diagnostics United States | 17 | 10 |
|
HSP, Supplemental Sporadic Evaluation Athena Diagnostics United States | 24 | 22 |
|
Athena Diagnostics United States | 40 | 24 |
|
HSP, Supplemental Dominant Evaluation Athena Diagnostics United States | 12 | 6 |
|
Asper Biogene Asper Biogene LLC Estonia | 39 | 38 |
|
Spastic paraplegia 8, autosomal dominant Bioarray Spain | 1 | 1 |
|
Hereditary Spastic Paraplegias (HSP) and differential diagnoses Panel CeGaT GmbH Germany | 147 | 143 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.